DrugPatentWatch Database Preview
Drugs with Dosage: RING
» See Plans and Pricing
Drugs with Dosage: RING
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | Dosage |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Sub Merck | NUVARING | ethinyl estradiol; etonogestrel | RING;VAGINAL | 021187-001 | Oct 3, 2001 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | RING;VAGINAL | |||
| Amneal | ELURYNG | ethinyl estradiol; etonogestrel | RING;VAGINAL | 210830-001 | Dec 11, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | RING;VAGINAL | |||
| Therapeuticsmd Inc | ANNOVERA | ethinyl estradiol; segesterone acetate | RING;VAGINAL | 209627-001 | Aug 10, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | RING;VAGINAL | ||||
| Therapeuticsmd Inc | ANNOVERA | ethinyl estradiol; segesterone acetate | RING;VAGINAL | 209627-001 | Aug 10, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | RING;VAGINAL | ||||
| Therapeuticsmd Inc | ANNOVERA | ethinyl estradiol; segesterone acetate | RING;VAGINAL | 209627-001 | Aug 10, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | RING;VAGINAL | ||||
| Therapeuticsmd Inc | ANNOVERA | ethinyl estradiol; segesterone acetate | RING;VAGINAL | 209627-001 | Aug 10, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | RING;VAGINAL | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration | >Dosage |
